维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="LAVASANIFAR A"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives 显示文摘	Binkhathlan Z Lavasanifar A	2013	Curr Canc- er Drug Targets2013，13，3：	1
2	Poly(ethylene oxide)-block-poly (L-amino acid) micelles for drug delivery显示文摘	Samuel J Kwon G S	2002	Advance Drug Delivery Rev2002，54，：	1
3	Amphiphilic block copolymers for drug delivery显示文摘	Adams M L Lavasanifar A Kwon G S	2003	J Pharm Sci2003，92，：	1
4	Micelles self-assembled from poly(ethylene oxide)-block poly(N-hexyl stearate l-aspartamide)by a solvent evaporation method:effect on the solubilization and hemolytic activity of amphotericin B显示文摘	LAVASANIFAR A SAMUEL J KWON G S	2001	Journal of Controlled Release2001，77，1：	1
5	Amphiphific block copolymers for drug delivery显示文摘	Adams M L Lavasanifar A Kwon G S	2003	Journal of Pharmaceutical Sciences2003，92，7：	1
6	显示文摘	Adams M L Lavasanifar A Kwon G S	2003	J Pharm Sci2003，92，7：	1
7	The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly(ethylene oxide)-block-poly(N-hexyl stearate-l-aspartamide)显示文摘	LAVASANIFAR A SAMUEL J KWON G S	2002	Journal of Controlled Release2002，79，1：	1
8	The effect of fatty acid substitution on the in vitro release of amphotericin B from micelles composed of poly( ethylene oxide)-block-poly (N-hexyl stearate aspartamide) 显示文摘	LAVASANIFAR A SAMUEL J KWON GS	2002	J Control Release2002，79，13：	1
9	Delivery ofrapamycin by PLGA nanoparticles enhances its suppressiveactivity on dendritic cells显示文摘	Haddadi A Elamanchili P Lavasanifar A	2008	J Biomed Mater Res A2008，84，4：	1
10	Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution 显示文摘	ALIABADI H M BROCKS D R LAVASANIFAR A	2005	Biomaterials2005，26，35：	1
11	Micelles self-assembled from poly (ethylene oxide)-block-poly (N-hexyl stearate L-aspartamide) by a solvent evaporation method: effect on the solubilization and haemolytic activity of amphotericin B 显示文摘	Lavasanifar A Samuel J Kwon G S	2001	Journal of Controlled Release2001，77，12：	1
12	Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution显示文摘	Aliabadi M Brocks D Lavasanifar A	2005	Biomaterials2005，26，35：	1
13	Amphiphilic block copolymers for drug delivery 显示文摘	ADAMS M L LAVASANIFAR A KWON G S	2003	J Pharm Sci2003，92，7：	1
14	P-glycoprotein inhibition as a thera- peutic approach for overcoming multidrug resistance in cancer: cur- rent status and future perspectives 显示文摘	Binkhathlan Z Lavasanifar A	2013	Curr Cancer Drug Targets2013，13，3：	1
15	Poly(ethylene oxide)block-poly (L-amino acid) micelles for drug delivery显示文摘	Lavasanifar A Samuel J Kwon G S	2002	Advanced Drug Delivery Reviews2002，54，：	1
16	显示文摘	Aliabadi H M Lavasanifar A	2006	Expert Opin Drug Deliv2006，3，1：	1
17	The effect of alkyl core structure on micellar properties of poly ( ethylene oxide ) -block- poly(Laspartamide) derivatlves显示文摘	Lavasanifar A Samuel J Kwon GS	2001	Colloids Surfaces B Bioint- effaces2001，22，：	1
18	P-glycoprotein inhibition as a therapeutic approach for overcoming multidrug resistance in cancer: current status and future perspectives 显示文摘	Binkhathlan Z Lavasanifar A	2013	Curr Cancer Drug Targets2013，13，3：	1
19	P-glycoprotein inhibition as a thera- peutic approach for overcoming multidrug resistance in cancer: current status and future perspectives 显示文摘	Binkhathlan Z Lavasanifar A	2013	Curr Cancer Drug Targets2013，13，3：	1
20	Poly ( ethyleneoxide)-block-poly (L-amino acid ) micelles for drug delivery 显示文摘	LAVASANIFAR A SAMUEL J KWON G S	2002	Adv Drug Deliv Rev2002，54，：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示